Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Hepatic Encephalopathy

• Efficacy of Lactoferrin as an Adjunct Therapy in Patients With Hepatic Encephalopathy
• Hepatic Encephalopathy and Albumin Lasting Cognitive Improvement
• Effectiveness of Oral Lactulose Versus Lactulose Enema in Hepatic Encephalopathy
• The Efficacy and Safety of Rifaximin Treatment
• Comparing Nifuroxazide Plus Lactulose With Lactulose Alone in the Treatment of Hepatic Encephalopathy
• Intravenous BCAA for HE in ACLF (BCAA-HE-ACLF)
• Efficacy of L-Ornithine L-Aspartate (LOLA) as an Adjunct to Branched Chain Amino Acids (BCAA) Enriched Solutions on Clinical Outcomes in ICU Patients With Hepatic Encephalopathy
• Allopurinol Versus Simvastatin to Prevent Complications of Liver Cirrhosis
• Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis
• Secondary Prophylaxis of Hepatic Encephalopathy in Cirrhotic Patients
• Integrated Traditional Chinese and Clinical Medicine for Chronic Hepatitis B and Its Complication
• Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis
• Deprescribing Proton Pump Inhibitors to Reduce Post-TIPS Hepatic Encephalopathy
• VE303 for Treatment of Hepatic Encephalopathy (HE)
• TReatment for ImmUne Mediated PathopHysiology
• Efficacy and Safety of AXA1665 in Cirrhotic Subjects With Prior Overt Hepatic Encephalopathy
• Efficacy and Safety of E.Coli Nissle 1917 in Patients With Mild (Stage 1-2) or Minimal Hepatic Encephalopathy
• Microbial Resistance of Rifaximin in Hepatic Encephalopathy
• Polyethylene Glycol Versus Lactulose on Hepatic Encephalopathy in Patients With Cirrhosis;(PEGHE Trial)
• Rifaximin's Effect on Covert Hepatic Encephalopathy With SIBO and Gastrointestinal Dysmotility
• Intravenous Branched Chain Amino Acids for Hepatic Encephalopathy in ACLF
• Efficacy and Safety of Nitazoxanide in Preventing Recurrence of Hepatic Encephalopathy
• MNK-6105 for Patients With Cirrhosis and High Ammonia Levels Affecting Brain Function
• Rifamycin in Minimal Hepatic Encephalopathy
• Prevention of Post-TIPS Hepatic Encephalopathy by Administration of Rifaximin and Lactulose
• PEG3350 in ACLF With Hepatic Encephalopathy
• Coenzyme Q10 and Meclofenoxate in Hepatic Encephalopathy
• FMT in Cirrhosis and Hepatic Encephalopathy
• MNK6106 for Liver Disease (Hepatic Cirrhosis) That in the Past Has Affected the Brain (Hepatic Encephalopathy)
• Rifaximin Soluble Solid Dispersion (SSD) Tablets Plus Lactulose for the Treatment of Overt Hepatic Encephalopathy (OHE)
• To Compare Efficacy and Safety of Lactulose Versus Polyethylene Glycol for Treatment of Overt Hepatic Encephalopathy in Cirrhotics.
• Fecal Microbiota Transplant as Treatment of Hepatic Encephalopathy
• To Assess Efficacy of Nutritional Therapy in Secondary Prophylaxis of Hepatic Encephalopathy Versus Lactulose in Patients With Liver Cirrhosis.
• Oral Fecal Transplant in Cirrhosis
• High Volume Plasmapheresis for Refractory Hepatic Encephalopathy in Liver Intensive Care Unit.
• PEG (Polyethylene Glycol)Versus Lactulose For Treatment Of Overt Hepatic Encephalopathy
• A RCT COMPARING LACTULOSE AND RIFAXIMIN ASSOCIATED WITH A VEGETABLE DIET IN THE PREVENTION OF POST-TIPS OVERT HEPATIC ENCEPHALOPATHY
• Metformin Experience on Minimal Hepatic Encephalopathy
• Nitazoxanide Plus Lactulose Versus Lactulose Alone Treatment of Hepatic Encephalopathy
• Effycacy of Rifaximin on Reverse Minimal Hepatic Encephalopathy and Elimation Small Intestinal Bacterial
• Albumin Infusion Effects in Mortality in Patients With Cirrhosis and Hepatic Encephalopathy
• The Effects of Nitazoxanide in Hepatic Encephalopathy
• Effect of Goal Directed Ammonia Lowering Therapy in Acute on Chronic Liver Failure Patients With Hepatic Encephalopathy.
• Acetyl-L-Carnitine Reduces Perceived Work Stress and Improves Work Ability and Work Performance in Hepatic Encephalopathy
• Effect of Rifaximine on Sleep Disorders in Patients Suffering From Hepatic Encephalopathy
• Lactulose, L-ornithine L-aspartate, or Rifaximin Versus Placebo for Preventing Hepatic Encephalopathy in Variceal Bleeding
• A Randomized Comparison of Rifaximin Versus Lactulose in Hospitalized Cirrhotic Patients With Renal Failure
• Treatment of Hepatic Encephalopathy With Flumazenil and Change in Cortical GABA Levels in MRS
• Efficacy of Sildenafil in the Improvement of Cognition and Quality of Life in Patients With Cirrhosis of Liver. A Proof of Concept Study.
• Randomised Controlled Trial of Mechanistic Effects of Rifaximin in Cirrhosis and Chronic Hepatic Encephalopathy
• Comparison Between Lactulose and Lactulose-Paraffin in Cirrhotic Patients
• Phase 2B Efficacy/Safety of Ornithine Phenylacetate in Hospitalized Cirrhotic Patients With Hepatic Encephalopathy (STOP-HE)
• Hepatic Encephalopathy: Lactulose or Polyethylene Glycol (H.E.L.P.)
• Brain Muscle Axis During Treatment of Hepatic Encephalopathy With L-ornithine L-aspartate
• The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy.
• Efficacy, Safety, And Pharmacokinetics Of Rifaximin In Subjects With Severe Hepatic Impairment And Hepatic Encephalopathy
• Single Dose Pharmacokinetics of Suboxone Study in Hepatic Impaired Subjects
• The Safety/Efficacy of Rifaximin With/Without Lactulose in Participants With A History of Recurrent Hepatic Encephalopathy
• Quality of Life and Nutritional Improvements in Cirrhotic Patients
• Diagnosis of Covert/Minimal Hepatic Encephalopathy by Means of Continuous Reaction Time Measurement
• L-ornithine L-aspartate in Overt Hepatic Encephalopathy
• Post Transjugular Intrahepatic Portosystemic Shunt (Tips) Albumine Infusion to Prevent Hepatic Encephalopathy
• Effect of Tolvaptan on Cognitive Function in Cirrhosis
• S. Endotoxin, Inflammatory Mediators and MRS Before and After Treatment in MHE
• Trial Comparing Sedation for Endoscopy With Propofol Versus Midazolam in Cirrhotics
• Efficacy Study of Polyethylene Glycol 3350-electrolyte Solution (GoLYTELY®) Versus Lactulose in Patients With Hepatic Encephalopathy.
• Acetyl-L-Carnitine In Severe Hepatic Encephalopathy
• Oral Acetyl-L-Carnitine Therapy Reduces Fatigue In Hepatic Encephalopathy
• Acetyl-L-Carnitine Reduces Depression and Improves Quality of Life in Patients With Minimal Hepatic Encephalopathy
• Rifaximin Plus Lactulose Versus Lactulose Alone for the Treatment of Hepatic Encephalopathy: a Double Blind Randomized Trial
• Secondary Prophylaxis of Hepatic Encephalopathy in Cirrhosis
• Primary Prophylaxis of Hepatic Encephalopathy in Patients With Cirrhosis
• Hyperproteic Diet Plus Lactobacillus Reuteri and Nitazoxanide in Minimal Hepatic Encephalopathy
• Secondary Prophylaxis of Hepatic Encephalopathy With a Probiotic Preparation
• Comparison Between Erythromycin and Neomycin Treatment of Hepatic Encephalopathy
• Study of Rifaximin in Minimal Hepatic Encephalopathy
• Study on B-blockers to Prevent Decompensation of Cirrhosis With HTPortal
• Efficacy of L-Ornithine L-Aspartate in Acute Hepatic Encephalopathy.
• Effect of Probiotics in Treatment of Minimal Hepatic Encephalopathy (MHE) and Health Related Quality of Life
• A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
• A Study of Glyceryl Tri-(4-phenylbutyrate) Administered Orally as a Single Dose, and Twice Daily for Seven Consecutive Days to Subjects With Hepatic Impairment With Cirrhosis and to a Control Group
• A Study of Controlled Lactulose Withdrawal
• Therapeutic Efficacy of Oral L-Ornithine-L-Aspartate on Minimal Encephalopathy
• Efficacy of Albumin for Acute Encephalopathy in Patients With Cirrhosis
• AST-120 Used to Treat Mild Hepatic Encephalopathy
• Effect of Midodrine and Albumine in the Prevention of Complications in Cirrhotic Patients Awaiting Liver Transplantation
• Study of Lactulose in Children With Chronic Liver Disease
• Efficacy of Combined Oral L-ornithine-L-aspartate and Lactulose in Patients With Hepatic Encephalopathy
• Safety and Tolerability Study of Rifaximin in Participants With a History of Hepatic Encephalopathy
• Efficacy and Safety Study of Ammonul® in Patients With Grade 3 or 4 Hepatic Encephalopathy
• Safety and Efficacy of AST-120 Compared to Lactulose in Patients With Hepatic Encephalopathy
• Lactulose for the Prevention of Hepatic Encephalopathy in Cirrhotic Patients With Upper Gastrointestinal Hemorrhage
• Rifaximin in Minimal Hepatic Encephalopathy
• Efficacy of L-Ornithine-L-Aspartate in Cirrhotics With Hepatic Encephalopathy
• Effect of Lactulose on Minimal Hepatic Encephalopathy and Health-Related Quality of Life
• RICE Trial: Rifaximin In Chronic Hepatic Encephalopathy - A Randomized, Controlled Trial
• Brain Imaging in Patients With Chronic Liver Disease and Functional Impairment.
• A 6-month Efficacy, Safety, and Tolerability Study of Rifaximin In Preventing Hepatic Encephalopathy
• Efficacy of Albumin Dialysis to Treat Patients With Hepatic Encephalopathy Using The Molecular Adsorbent Recirculating System (MARS)
• The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy
• N-acetylcysteine in Non-Acetaminophen Pediatric Acute Liver Failure
• Phase II Study of Lactulose and Circadian Rhythms in Patients With Cirrhosis